The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

AlzheimerNews

News The 2018 Revised FDA Guidance for Early Alzheimer’s Disease: Establishing the Meaningfulness of Treatment Effects

The present report reviews the revised 2018 FDA guidance for early AD, with an emphasis on meaningfulness of clinical outcome assessments (COAs). A radical shift is evident in the importance given to establishing the meaningfulness of COAs in the 2018… Continue Reading →

News Implementing a memory clinic model to facilitate recruitment into early phase clinical trials for mild cognitive impairment and alzheimer’s disease

 Our objective was to significantly facilitate recruitment into AD clinical trials by providing resources and education to patients, their treating physicians, and caregivers in the community. Park, C. Kouhanim, S. Lee, Z. Mendoza, K. Patrick, L. Gertsik, C. Aguilar, D…. Continue Reading →

News Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: an EU/US CTAD Task Force Report

There is an urgent need to develop reliable and sensitive bloodbased biomarkers of Alzheimer’s disease (AD) that can be used for screening and to increase the efficiency of clinical trials. The European Union-North American Clinical Trials in Alzheimer’s Disease Task… Continue Reading →

© 2019 Aging-news — Powered by WordPress

Theme inspired by Anders NorenUp ↑